Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The myocardial cell apoptosis pathway refers to a network of signaling cascades that mediate programmed cell death in cardiomyocytes. This process involves both intrinsic (mitochondrial-mediated) and extrinsic (death receptor-mediated) pathways, with critical roles for Bcl-2 family proteins, caspases, and cellular organelles such as mitochondria. Dysregulation of apoptosis in myocardial tissue is implicated in the pathogenesis of heart failure, myocardial infarction, and cardiotoxicity associated with chemotherapeutic agents. Various molecules within these pathways, such as caspases, Bcl-2 family members, and death receptors, have been investigated as potential therapeutic targets, but the pathway itself is not a single pharmacological target.
Inhibition or activation of caspases (caspase-3, caspase-8, caspase-9) Modulation of Bcl-2 family proteins (pro- and anti-apoptotic) Inhibition of mitochondrial permeability transition and cytochrome c release Regulation of MAPK signaling pathways (ERK, JNK, p38) Blocking death receptor (e.g., Fas/TNF receptors) pathways Inhibition of NLRP3 inflammasome/pyroptosis (for agents like MCC950)
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Myocardial cell apoptosis pathway.